Company Name: Seattle Genetics, Inc.    

Seattle Genetics, Inc. is a biotechnology company. The company is engaged in the development and commercialization of antibody-based therapies designed to treat cancer. The company’s antibody-drug conjugate (ADC) technology is designed to allow cell killing agents to be delivered directly to cancer cells. ADCETRIS®, the company’s lead product, is approved in over 50 countries.

Ticker Symbol: SGEN (NASDAQ)

Company Website:

Social Media:

Seattle Genetics LinkedIn

Seattle Genetics Twitter

Headquarters: Bothell, WA